Wells Fargo Starts Golar LNG Ltd. (GLNG) at Market Perform; Looking For A Better Entry on This High-Flyer
Get Alerts GLNG Hot Sheet
Price: $52.49 +2.50%
Rating Summary:
17 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo initiates coverage on Golar LNG Ltd. (NASDAQ: GLNG) with a Market Perform. PT range $39-$43.
Wells analyst said, "We have initiated coverage of Golar LNG with a Market Perform rating as we believe tight LNG market fundamentals and the company's sector-leading growth are largely reflected in GLNG's share price at this point. While we expect LNG fundamentals to remain firm over the intermediate term (with short-term rates north of $140,000 per day), we believe GLNG's recent upside (up 294% over the past 18 months, versus the S&P 500, up 34%) has taken its valuation to a more appropriate level."
For an analyst ratings summary and ratings history on Golar LNG Ltd. click here. For more ratings news on Golar LNG Ltd. click here.
Shares of Golar LNG Ltd. closed at $40.25 yesterday.
Wells analyst said, "We have initiated coverage of Golar LNG with a Market Perform rating as we believe tight LNG market fundamentals and the company's sector-leading growth are largely reflected in GLNG's share price at this point. While we expect LNG fundamentals to remain firm over the intermediate term (with short-term rates north of $140,000 per day), we believe GLNG's recent upside (up 294% over the past 18 months, versus the S&P 500, up 34%) has taken its valuation to a more appropriate level."
For an analyst ratings summary and ratings history on Golar LNG Ltd. click here. For more ratings news on Golar LNG Ltd. click here.
Shares of Golar LNG Ltd. closed at $40.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Leerink Starts Ligand Pharma (LGND) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Standard & Poor's, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share